USPSTF updates guidance on preventative statins use for CVD

The US Preventive Services Task Force (USPSTF) recommended that adults aged 40 to 75 years without prior cardiovascular disease (CVD), events who are at an increased risk for CVD with an estimated 10-year CVD event risk of ≥10%, should be prescribed a statin for the primary prevention of CVD, while similar adults with an estimated 10-year CVD risk of 7.5% to <10% should be selectively offered a statin, according to recommendations published in JAMA.

The current recommendations are mostly unchanged from the 2016 recommendations.

The full list of recommendations can be found here.

Reference
Chou R, Cantor A, Dana T, Wagner J, Ahmed AY, Fu R, Ferencik M. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2022 Aug 23;328(8):754-771. doi: 10.1001/jama.2022.12138. PMID: 35997724.